MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$79,996K
Net loss
-$78,729K
Foreign currency
translation adjustments
-$1,217K
Unrealized gain (loss) on
available-for-sale securities
-$50K
Loss before income
taxes
-$77,059K
Income tax expense
$1,670K
Interest income
$6,382K
Research and development
tax credits
$752K
Grant income
$183K
Loss from operations
-$83,791K
Other (expense)
income, net
-$585K
Total operating
expenses
$83,791K
Research and development
expenses
$57,275K
Restructuring costs
$16,335K
General and
administrative expenses
$10,181K
Back
Back
Income Statement
source: myfinsight.com
iTeos Therapeutics, Inc. (ITOS)
iTeos Therapeutics, Inc. (ITOS)